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a b s t r a c t
The asymmetric synthesis of 8-deoxypumiliotoxin 193H and 9-deoxyhomopumiliotoxin 207O has been
achieved, starting from both enantiomers of (+)- and ()-10. Enantiomerically pure alcohols (+)- and ()-
10 were obtained by lipase-mediated kinetic resolution of racemic 10, which was prepared in 3 steps
from new lactam-type building block ()-8 in a highly stereoselective manner.
 2018 Published by Elsevier Ltd.
Introduction
To date, over 800 lipophilic alkaloids representing >20 struc-
tural classes have been detected from the skin extracts of poison
frogs [1]. Pumiliotoxins (PTXs, 1) are one of the major classes of
frog alkaloids, and their structural diversity and pharmacological
activity have stimulated considerable interest in their chemical
synthesis by several groups. At present, over 30 alkaloids are
considered to be PTXs and over 60 alkaloids belong to various
congeners, such as homopumiliotoxins (hPTXs, 2), 8-deoxy-
pumiliotoxins (8-deoxy-PTXs, 3), 9-deoxy-homopumiliotoxins (9-
deoxy-hPTXs, 4), 8-desmethyl-pumiliotoxins (8-desmethyl-PTXs,
5), and 9-desmethyl-homopumiliotoxins (9-desmethyl-hPTXs, 6)
(Fig. 1).
Some of the proposed structures for PTXs are tentative, while
others have been rigorously established by MS, FT-IR, NMR spectra,
and/or synthesis. Among PTXs, over 10 enantioselective syntheses
of PTX 251D have been reported [2]; however, only one synthesis
of 8-deoxy-PTX 193H has been reported to date [3].
As part of a larger research program directed at studying the
synthesis of poison frog alkaloids [4], we report here the asymmet-
ric synthesis of 8-deoxy-PTX 193H and 9-deoxy-hPTX 207O
(Fig. 2).
Results and discussion
The synthesis began with b-keto ester (±)-7, which was pre-
pared in 3 steps from allylamine [5]. Reduction of (±)-7with NaBH4
gave to the racemic alcohol (±)-8 in low yield, while bakers’ yeast
reduction of (±)-7 under nonfermenting conditions gave rise to the
enantiopure alcohol ()-8 in good yield and high optical purity
(>98% ee) [6]. Treatment of ()-8 with bis(2-methoxyethyl) azodi-
carboxylate and Ph3P provided the enaminoester (±)-9, which was
subjected to copper-mediated 1,4-addition of methyllithium, fol-
lowed by reduction of the resulting adduct with Super-Hydride
to afford the primary alcohol (±)-10 in high yield as a single isomer
(Scheme 1).
To obtain both enantiomers of (+)- and ()-10, lipase-mediated
kinetic resolution of (±)-10 with lipase PL and vinyl acetate in t-
BuOMe was conducted, and resulted in the acetate 11 in 55% yield
with 58% ee, and the alcohol ()-10 in 36% yield with >98% ee,
respectively. Since the ee of the acetate 11 from the initial resolu-
tion was not sufficient for further transformation, the acetate 11
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was hydrolyzed to the corresponding alcohol 10, which was then
subjected to a second kinetic resolution under the same reaction
conditions to obtain the acetate (+)-11. Hydrolysis of the enantiop-
ure acetate (+)-11 with NaOH gave the enantiopure alcohol (+)-10
with 98% ee (Scheme 2).
Once both enantiomers of 10 were obtained, we performed a
Swern oxidation of ()-10, which was followed by a Wittig reac-
tion of the resulting aldehyde. The Wittig reaction provided the
olefin ()-12, which was converted to the tetrahydroindolizin-5-
one ()-13 by ring-closing metathesis using a 2nd generation
Grubbs catalyst. Hydrogenation of (-)-13 over 10% Pd/C resulted
in the indolizidinone ()-14. The absolute stereochemistry of
()-10 was determined to be 5R, 6R by comparing the optical rota-
tion between our synthetic ()-14 with known (+)-14 [7].
Indolizidinone ()-14 was subjected to an aldol condensation with
isobutyraldehyde to afford the aldol adduct 15. Stereospecific syn-
elimination of 15 using DCC/CuCl [2b] afforded the desired (Z)-
olefin ()-16 with no (E)- olefin. Finally, a reduction of the
lactam moiety of ()-16 using AlH3, resulted in the formation of
()-8-deoxy-PTX 193H (Scheme 3). The 1H and 13C NMR spectra
of our synthetic ()-8-deoxy-PTX 193H were in good accordance
with data from the literature, however the optical rotation was
opposite [3].
The enantiomer (+)-8-deoxy-PTX 193H was also synthesized
from (+)-10 in the same manner as shown in Scheme 3.
Furthermore, both enantiomers of (+)- and ()-9-deoxy-hPTX
207O were also synthesized from the alcohols ()- and (+)-10.
The alcohol ()-10 was converted to the iodide (+)-17, which
was subjected to a cross-coupling reaction with vinylmagnesium
chloride in the presence of HMPA and P(OEt)3 [8] to afford the dial-
lylpiperidone ()-18 in 62% yield, together with the undesired
ring-opening amide 19 in 22% yield, respectively. The ring-closing
methathesis reaction of ()-18 using a 2nd generation Grubbs cat-
alyst, followed by hydrogenation of the resulting olefin (-)-20, pro-
vided the quinolizidinone (+)-21 [9], which was subjected to an
aldol condensation to afford the aldol adduct 22. Stereospecific
syn-elimination of 22 using DCC/CuCl gave the undesired (E)-olefin
(+)-23a in 81% yield, while anti-elimination [2b] by mesylation of
22, followed by treatment of the resulting meslate with KOH,
provided the desired (Z)-olefin (+)-23b in 70% yield in 2 steps.
The double bond geometry in (+)-23a and (+)-23b was
determined based on the chemical shift of the vinyl proton using
1H NMR spectra. The vinyl proton of the (Z)-olefin (+)-23b was
detected in a high magnetic field (d 5.45 ppm), while that of the
(E)-olefin (+)-23a was present in a low magnetic field (d
6.56 ppm) due to the anisotropy of the amide-carbonyl group.
These results are very similar to those of previous report [10]. It
was noteworthy that the aldol adducts for indolizidinone 14 and
quinolizidinone 21 were opposite. Finally, reduction of (+)-23b
by treatment with AlH3 resulted in the formation of (+)-deoxy-
hPTX 207O (Scheme 4). The enantiomer ()-deoxy-hPTX 207O
was also synthesized from (+)-10 in the same manner as shown
in Scheme 4.
Fig. 1. Structures of pumiliotoxins and various congeners.
Fig. 2. Structures of PTX 251D, 8-deoxy-PTX 193H, and 9-deoxy-hPTX 207O.
Scheme 1. Reagents and conditions: (a) 1.05 eq. Ethyl bromoacetate, 1.05 eq. Et3N,
CH2Cl2, r.t.; (b) 1.2 eq. Ethyl succinyl chloride, 1.2 eq. Et3N, CH2Cl2, r.t.; (c) 1.1 eq.
NaH, THF, r.t. (70% in 3 steps); (d) bakers’ yeast, tap water, r.t. (76%, >98% ee); (e)
1.1 eq. bis(2-methoxyethyl) azodicarboxylate, 1.1 eq. Ph3P, r.t. (94%); (f) 2.5 eq.
Me2CuLi, Et2O, 78 to 0 C; (g) 3.0 eq. Super-Hydride, THF, r.t. (92% in 2 steps).
Scheme 2. Reagents and conditions: (a) lipase PL, vinyl acetate, t-BuOMe, r.t. ((+)-
11: 55%, 58% ee, ()-10: 36%, >98% ee); (b) 6 M NaOH (aq.), EtOH, r.t. (84%); (c)
lipase PL, vinyl acetate, t-BuOMe, r.t. (47%); (d) 6 M NaOH (aq.), EtOH, r.t. (93%, 98%
ee).
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Conclusion
We have achieved the asymmetric synthesis of both enan-
tiomers of 8-deoxy-PTX 193H and 9-deoxy-hPTX 207O from the
common enantiopure alcohol 10. Furthermore, we are trying to
synthesize 8-desmethyl-PTXs and 9-desmethyl-hPTXs from the
enantiopure alcohol ()-8. The antagonistic activities of both enan-
tiomers of these PTX alkaloids against nicotinic acetylcholine
receptors are now in progress.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.tetlet.2018.09.015.
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